“Simple, generic white kidney bean extracts...will not provide the benefits nor the safety as described on the Dr. Oz program,” stated Mitch Skop.
Television personality Dr. Oz has been promoting white kidney bean extract as an effective ingredient for reducing starch digestion and aiding in weight control. However, Phase 2 brand white kidney bean extract supplier Pharmachem Laboratories Inc. (Kearny, NJ) is reminding consumers that only its patented formula has been clinically studied and shown to support these effects.
“Simple, generic white kidney bean extracts do not offer adequate potency or stability to perform like Phase 2 and will not provide the benefits nor the safety as described on the Dr. Oz program,” stated Mitch Skop, Pharmachem’s director of new product development. “We are ecstatic over the coverage…and worked with Dr. Oz’s diet and fitness expert, Lisa Lynn, providing background for her interviews, and are pleased with the attention. However, of late we have become concerned about interesting new products labeled simply as ‘white kidney bean extract.’”
While the company believes Dr. Oz promoted the benefits white kidney bean extracts after being impressed by the ingredient’s research, Skop reminded the public that “Phase 2 is the first clinically studied extract of the white kidney bean shown to reduce starch digestion and aid in weight control. It is the only white bean extract backed by numerous clinical studies for efficacy and is GRAS.”
“Generic white kidney beans have no similar studies, and thus cannot make claims about starch reduction or weight control…” he concluded.
Pharmachem says it is requested that Dr. Oz reference the Phase 2 brand name in any future stories he does on white kidney bean extract. “Ultimately, it’s about making sure the customer and the consumer are getting the proper information about what they are buying, and aren’t being fooled by imitations riding on our research,” Skop said. “Unfortunately, it is a phenomenon that occurs all too often in our industry.”
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
Microalgae extract supports metabolic health and bone mass during diet and exercise routine
April 11th 2024The extract from Microphyt, called PhaeOptim, was shown to complement weight management strategies that include diet and exercise by support bone mass, aerobic capacity, resting heart rate, and blood lipid profiles.